Cardiac Imaging

While cardiac ultrasound is the widely used imaging modality for heart assessments, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging are also used and are often complimentary, each offering specific details about the heart other modalities cannot. For this reason the clinical question being asked often determines the imaging test that will be used.

Q&A: What cardiologists know and don’t know about pulsed field ablation
Peter Weiss, MD, a veteran electrophysiologist, sat down with Cardiovascular Business to discuss the ongoing rise of pulsed field ablation. While he's impressed with the technology, he says many questions remain about its long-term value.
FDA details Class I recalls for more than 1 million pacemakers—software update required
The FDA has finalized new Class I recalls related to ongoing safety concerns with Boston Scientific’s Accolade family of pacemakers. A software update is now available to help address the issue, and an additional update is already in the works.
Medtronic launches full distribution of new 3-in-1 carotid stent
The device, manufactured by Contego Medical, was designed with rising procedure volumes and stroke risks in mind.
FDA approves Zoll's newest defibrillator-monitor
The device, based on years of user feedback, is now cleared for use in both EMS and hospital settings.
Multimodality imaging is more important than ever to the field of cardio-oncology
“Multimodality imaging in cardio-oncology is something many of us in the field are truly excited about," Daniel Addison, MD, told Cardiovascular Business. He noted that modalities other than echocardiography are starting to play a much larger role in the treatment of these patients.

Q&A: What cardiologists know and don’t know about pulsed field ablation

Peter Weiss, MD, a veteran electrophysiologist, sat down with Cardiovascular Business to discuss the ongoing rise of pulsed field ablation. While he's impressed with the technology, he says many questions remain about its long-term value.

FDA details Class I recalls for more than 1 million pacemakers—software update required

The FDA has finalized new Class I recalls related to ongoing safety concerns with Boston Scientific’s Accolade family of pacemakers. A software update is now available to help address the issue, and an additional update is already in the works.

Contego Medical, a North Carolina-based medical device company, has received U.S. Food and Drug Administration (FDA) approval for its new all-in-one carotid stenting offering, the Neuroguard IEP System

Medtronic launches full distribution of new 3-in-1 carotid stent

The device, manufactured by Contego Medical, was designed with rising procedure volumes and stroke risks in mind.

The U.S. Food and Drug Administration (FDA) granted pre-market approval (PMA) clearance for Zoll Zenix defibrillator-monitor for EMS and hospital use. It incorporates new technology and features based on years of user feedback.

FDA approves Zoll's newest defibrillator-monitor

The device, based on years of user feedback, is now cleared for use in both EMS and hospital settings.

As cancer therapies become increasingly targeted and complex, the need for sophisticated cardiovascular monitoring has grown in parallel. Cardiovascular Business spoke with Daniel Addison, MD, director of the cardio-oncology program at The Ohio State University and chair of the American Heart Association’s (AHA) Cardiac Imaging Committee, who said the use of multimodality imaging is transforming how clinicians manage cardiovascular risk in cancer patients and survivors.

Multimodality imaging is more important than ever to the field of cardio-oncology

“Multimodality imaging in cardio-oncology is something many of us in the field are truly excited about," Daniel Addison, MD, told Cardiovascular Business. He noted that modalities other than echocardiography are starting to play a much larger role in the treatment of these patients.

‘Every second counts’: New Viz.ai platform brings the entire heart attack team together

The new platform provides users with real-time access to high-quality electrocardiograms and patient data. The goal is to ensure everyone is on the same page at all times, with no unnecessary delays.

FDA clears new AI model for MAC detection in routine imaging results

The advanced algorithm was designed to detect and evaluate mitral annular calcification on routine, non-gated CT scans. It is now available as part of Carebricks, a generative AI platform from Bunkerhill Health.

SCAI highlights the benefits of ICE-guided structural heart interventions

ICE is gaining momentum as a helpful imaging option during structural heart interventions, according to a new SCAI position statement. TEE and TTE remain incredibly important, but there are times when ICE can provide the guidance necessary.